The deal is the second auction sale of Aceto’s assets under a Chapter 11 bankruptcy filing.
New Mountain Capital, which has more than $20 billion in assets under management, will take over ownership of Aceto’s chemical division.
The deal was approved in bankruptcy court April 16.
Last week, Aceto secured court approval to sell its struggling generic drugs unit to a drugmaker in India for $15 million.
More articles on pharmacy:
PBM hearing should prompt bill to ban ‘secrecy’ in drug industry, senator says
Republicans tell drugmakers that complying with House probe could hurt their stock prices
Hawaii primary care network opens in-house pharmacy
